Enhancement of fibrinolytic potential in vitro by anticoagulant drugs targeting activated factor X, but not by those inhibiting thrombin or tissue factor-Reference-Cited by-同舟云学术

Enhancement of fibrinolytic potential in vitro by anticoagulant drugs targeting activated factor X, but not by those inhibiting thrombin or tissue factor

Published:2003-09 Issue:6 Volume:14 Page:557-562
ISSN:0957-5235
Container-title:Blood Coagulation & Fibrinolysis
language:en
Short-container-title:Blood Coagulation & Fibrinolysis

Author:

Lisman Ton,Adelmeijer Jelle,Nieuwenhuis H Karel,de Groot Philip G

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology,General Medicine

Reference29 articles.

1. Fondaparinux Sodium

2. Lasting safe interruption of endarterectomy thrombosis by transiently infused antithrombin peptide D-Phe-Pro-ArgCH2Cl in baboons

3. Hirudin and hirudin analogues as new anticoagulant agents

4. Active site-blocked activated factor VII as an effective antithrombotic agent: mechanism of action

5. Tissue Factor Pathway Inhibitor: Potential Therapeutic Applications

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Historical Perspective on the Reversal of Anticoagulants;Seminars in Thrombosis and Hemostasis;2022-09-02

2. Management and Outcomes of Patients with Isolated Superficial Vein Thrombosis under Real Life Conditions (INSIGHTS-SVT);European Journal of Vascular and Endovascular Surgery;2021-08

3. Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability;Thrombosis Research;2021-05

4. Effect of anticoagulants on fibrin clot structure: A comparison between vitamin K antagonists and factor Xa inhibitors;Research and Practice in Thrombosis and Haemostasis;2020-10-25

5. In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation;Journal of Thrombosis and Haemostasis;2020-09